Amphotericin B-deoxycholate overdose due to administration error in pediatric patients

Susanne Groeneveld Departments of Pediatrics, the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Paul E. Verweij Medical Microbiology, the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Louis Van't Hek Pediatric Intensive Care, the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Jos P.M. Bökkerink Pediatric Oncology, the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

Adilia Warris Departments of Pediatrics, the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; the Nijmegen University Center of Infectious Disease, Radboud University Nijmegen Medical Center, Nijmegen, the NetherlandsCorrespondence[email protected]

, PhD , MD

References

Mohr JF, Hall AC, Ericsson CD, Ostrosky-Zeichner L. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation. Pharmacother 2005; 25: 426–428
Google Scholar
Cleary JD, Hayman J, Sherwood J, Lasala GP, Piazza-Hepp T. Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Pharmacother 1993; 27: 715–719
PubMed Web of Science ®Google Scholar
Perlman JM, Acarregui M, Gard JW. Fatal overdose of amphotericin B in two preterm infants. Dev Pharmacol Ther 1991; 17: 187–190
Google Scholar
Barcia JP. Hyperkalemia assosciated with rapid infusion of conventional and lipid complex formulations of amphotericin B. Pharmacother 1998; 18: 874–876
PubMed Web of Science ®Google Scholar
Oude Lashof, AML, Kullberg, BJ. Amphotericin B: the end of an era. Ned Tijdschr Geneeskund 2004; 148: 1665–1668. ( in Dutch).
Google Scholar
Kleinberg M. What is the current and future status of conventional amphotericin B?. Int J Antimicrob Agents 2006; 27S: 12–16
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Amphotericin B-deoxycholate overdose due to administration error in pediatric patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Amphotericin B-deoxycholate overdose due to administration error in pediatric patients

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date